Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia

NCT03483948 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Slow Enrollment

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: HMPL-523
DRUG: Azacitidine

Sponsor

Hutchison Medipharma Limited